Early diagnosis of resistant pathogens: How can it improve antimicrobial treatment?

Virulence

Volumn 4, Issue 2, 2013, Pages 172-184

  Bhattacharya, Sanjay ^a  

^a TATA MEDICAL CENTER   (India)

Author keywords

Antimicrobial therapy; Carbapenem resistance; Early diagnosis; ESBL; Infection control; Mdros (multidrug resistant organisms); MRSA; PCR; Surveillance culture; VRE

Indexed keywords

AMINOGLYCOSIDE; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; BETA LACTAM; CARBAPENEM; CEFEPIME; CEPHALOSPORIN; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLINDAMYCIN; DAPTOMYCIN; ERYTHROMYCIN; FOSFOMYCIN; GLYCOPEPTIDE; GLYCYLCYCLINE DERIVATIVE; IMIPENEM; LINEZOLID; LIPOPEPTIDE; MEROPENEM; OXAZOLIDINONE DERIVATIVE; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SULFONAMIDE; TEICOPLANIN; TIGECYCLINE; UNINDEXED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; BACTERIAL TRANSMISSION; BACTERIUM ISOLATION; COST EFFECTIVENESS ANALYSIS; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; DRUG EXPOSURE; EARLY DIAGNOSIS; ECONOMIC ASPECT; FOOD CHAIN; HEALTH CARE PERSONNEL; HOSPITALIZATION COST; HUMAN; KLEBSIELLA PNEUMONIAE; LOADING DRUG DOSE; META ANALYSIS (TOPIC); METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MICROARRAY ANALYSIS; MORBIDITY; MORTALITY; MULTIDRUG RESISTANCE; NONHUMAN; PRACTICE GUIDELINE; PREVALENCE; REAL TIME POLYMERASE CHAIN REACTION; RECURRENT DISEASE; REINFECTION; RESPIRATORY CARE; RISK FACTOR; SENSITIVITY AND SPECIFICITY; VANCOMYCIN RESISTANT ENTEROCOCCUS; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 84874201094     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: 10.4161/viru.23326     Document Type: Article

References (73)

1. Maragakis LL, Winkler A, Tucker MG, Cosgrove SE, Ross T, Lawson E, et al. Outbreak of multidrugresistant Serratia marcescens infection in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2008; 29:418-423; PMID:18419363; http://dx.doi.org/10.1086/587969
2. Kalter HD, Gilman RH, Moulton LH, Cullotta AR, Cabrera L, Velapatiño B. Risk factors for antibiotic-resistant Escherichia coli carriage in young children in Peru: community-based cross-sectional prevalence study. Am J Trop Med Hyg 2010; 82:879-888; PMID:20439971; http://dx.doi.org/10.4269/ajtmh.2010.09-0143
3. Leverstein-van Hall MA, Dierikx CM, Cohen Stuart J, Voets GM, van den Munckhof MP, van Essen-Zandbergen A, et al.; National ESBL surveillance group. Dutch patients, retail chicken meat and poultry share the same ESBL genes, plasmids and strains. Clin Microbiol Infect 2011; 17:873-880; PMID:21463397; http://dx.doi.org/10.1111/j.1469-0691.2011.03497.x.
4. Nguyen M, Eschenauer GA, Bryan M, O'Neil K, Furuya EY, Della-Latta P, et al. Carbapenemresistant Klebsiella pneumoniae bacteremia: factors correlated with clinical and microbiologic outcomes. Diagn Microbiol Infect Dis 2010; 67:180-184; PMID:20356699; http://dx.doi.org/10.1016/j.diagmicrobio.2010.02.001
5. Borer A, Saidel-Odes L, Riesenberg K, Eskira S, Peled N, Nativ R, et al. Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia. Infect Control Hosp Epidemiol 2009; 30:972-976; PMID:19712030; http://dx.doi.org/10.1086/605922
6. Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 2008; 29:1099-1106; PMID:18973455; http://dx.doi.org/10.1086/592412.
7. Ganga R, Riederer K, Sharma M, Fakih MG, Johnson LB, Shemes S, et al. Role of SCCmec type in outcome of Staphylococcus aureus bacteremia in a single medical center. J Clin Microbiol 2009; 47:590-5; PMID:19144813; http://dx.doi.org/10.1128/JCM.00397-08.
8. Micek ST, Reichley RM, Kollef MH. Health careassociated pneumonia (HCAP): empiric antibiotics targeting methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa predict optimal outcome. Medicine (Baltimore) 2011; 90:390-5; PMID:22033455; http://dx.doi.org/10.1097/MD.0b013e318239cf0a.
9. Houck PM, Bratzler DW, Nsa W, Ma A, Bartlett JG. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with communityacquired pneumonia. Arch Intern Med 2004; 164:637-44; PMID:15037492; http://dx.doi.org/10.1001/archinte.164.6.637.
10. Gaieski DF, Mikkelsen ME, Band RA, Pines JM, Massone R, Furia FF, et al. Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department. Crit Care Med 2010; 38:1045-53; PMID:20048677; http://dx.doi.org/10.1097/CCM.0b013e3181cc4824.
11. Kanwar M, Brar N, Khatib R, Fakih MG. Misdiagnosis of community-acquired pneumonia and inappropriate utilization of antibiotics: side effects of the 4-h antibiotic administration rule. Chest 2007; 131:1865-9; PMID:17400668; http://dx.doi.org/10.1378/chest.07-0164.
12. Ben-David D, Maor Y, Keller N, Regev-Yochay G, Tal I, Shachar D, et al. Potential role of active surveillance in the control of a hospital-wide outbreak of carbapenem-resistant Klebsiella pneumoniae infection. Infect Control Hosp Epidemiol 2010; 31:620-6; PMID:20370465; http://dx.doi.org/10.1086/652528.
13. Kochar S, Sheard T, Sharma R, Hui A, Tolentino E, Allen G, et al. Success of an infection control program to reduce the spread of carbapenem-resistant Klebsiella pneumoniae. Infect Control Hosp Epidemiol 2009; 30:447-52; PMID:19301985; http://dx.doi.org/10.1086/596734.
14. Blot S, Depuydt P, Vogelaers D, Decruyenaere J, De Waele J, Hoste E, et al. Colonization status and appropriate antibiotic therapy for nosocomial bacteremia caused by antibiotic-resistant gram-negative bacteria in an intensive care unit. Infect Control Hosp Epidemiol 2005; 26:575-9; PMID:16018434; http://dx.doi.org/10.1086/502575.
15. Papadomichelakis E, Kontopidou F, Antoniadou A, Poulakou G, Koratzanis E, Kopterides P, et al. Screening for resistant gram-negative microorganisms to guide empiric therapy of subsequent infection. Intensive Care Med 2008; 34:2169-75; PMID:18712349; http://dx.doi.org/10.1007/s00134-008-1247-9.
16. Ben-Ami R, Rodríguez-Baño J, Arslan H, Pitout JD, Quentin C, Calbo ES, et al. A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients. Clin Infect Dis 2009; 49:682-90; PMID:19622043; http://dx.doi.org/10.1086/604713.
17. Lonchel CM, Meex C, Gangoué-Piéboji J, Boreux R, Assoumou MC, Melin P, et al. Proportion of extendedspectrum ß-lactamase-producing Enterobacteriaceae in community setting in Ngaoundere, Cameroon. BMC Infect Dis 2012; 12:53; PMID:22405322; http://dx.doi.org/10.1186/1471-2334-12-53.
18. Overdevest I, Willemsen I, Rijnsburger M, Eustace A, Xu L, Hawkey P, et al. Extended-spectrum β-lactamase genes of Escherichia coli in chicken meat and humans, The Netherlands. Emerg Infect Dis 2011; 17:1216-22; PMID:21762575; http://dx.doi.org/10.3201/eid1707.110209.
19. Hanberger H, Nilsson LE, Claesson B, Kärnell A, Larsson P, Rylander M, et al. New species-related MIC breakpoints for early detection of development of resistance among gram-negative bacteria in Swedish intensive care units. J Antimicrob Chemother 1999; 44:611-9; PMID:10552977; http://dx.doi.org/10.1093/jac/44.5.611.
20. Adler A, Navon-Venezia S, Moran-Gilad J, Marcos E, Schwartz D, Carmeli Y. Laboratory and clinical evaluation of screening agar plates for detection of carbapenem-resistant Enterobacteriaceae from surveillance rectal swabs. J Clin Microbiol 2011; 49:2239-42; PMID:21471338; http://dx.doi.org/10.1128/JCM.02566-10.
21. Landman D, Salvani JK, Bratu S, Quale J. Evaluation of techniques for detection of carbapenem-resistant Klebsiella pneumoniae in stool surveillance cultures. J Clin Microbiol 2005; 43:5639-41; PMID:16272497; http://dx.doi.org/10.1128/JCM.43.11.5639-5641.2005.
22. Depuydt P, Benoit D, Vogelaers D, Claeys G, Verschraegen G, Vandewoude K, et al. Outcome in bacteremia associated with nosocomial pneumonia and the impact of pathogen prediction by tracheal surveillance cultures. Intensive Care Med 2006; 32:1773-81; PMID:16983549; http://dx.doi.org/10.1007/s00134-006-0354-8.
23. Depuydt PO, Blot SI, Benoit DD, Claeys GW, Verschraegen GL, Vandewoude KH, et al. Antimicrobial resistance in nosocomial bloodstream infection associated with pneumonia and the value of systematic surveillance cultures in an adult intensive care unit. Crit Care Med 2006; 34:653-9; PMID:16505649; http://dx.doi.org/10.1097/01.CCM.0000201405.16525.34.
24. Michel F, Franceschini B, Berger P, Arnal JM, Gainnier M, Sainty JM, et al. Early antibiotic treatment for BAL-confirmed ventilator-associated pneumonia: a role for routine endotracheal aspirate cultures. Chest 2005; 127:589-97; PMID:15706001; http://dx.doi.org/10.1378/chest.127.2.589.
25. Stamper PD, Louie L, Wong H, Simor AE, Farley JE, Carroll KC. Genotypic and phenotypic characterization of methicillin-susceptible Staphylococcus aureus isolates misidentified as methicillin-resistant Staphylococcus aureus by the BD GeneOhm MRSA assay. J Clin Microbiol 2011; 49:1240-4; PMID:21307210; http://dx.doi.org/10.1128/JCM.02220-10.
26. Schechner V, Straus-Robinson K, Schwartz D, Pfeffer I, Tarabeia J, Moskovich R, et al. Evaluation of PCR-based testing for surveillance of KPC-producing carbapenemresistant members of the Enterobacteriaceae family. J Clin Microbiol 2009; 47:3261-5; PMID:19675211; http://dx.doi.org/10.1128/JCM.02368-08.
27. Satake S, Clark N, Rimland D, Nolte FS, Tenover FC. Detection of vancomycin-resistant enterococci in fecal samples by PCR. J Clin Microbiol 1997; 35:2325-30; PMID:9276411.
28. Chapin KC, Musgnug MC. Direct susceptibility testing of positive blood cultures by using Sensititre broth microdilution plates. J Clin Microbiol 2003; 41:4751-4; PMID:14532215; http://dx.doi.org/10.1128/JCM.41.10.4751-4754.2003.
29. Ling TK, Liu ZK, Cheng AF. Evaluation of the VITEK 2 system for rapid direct identification and susceptibility testing of gram-negative bacilli from positive blood cultures. J Clin Microbiol 2003; 41:4705-7; PMID:14532207; http://dx.doi.org/10.1128/JCM.41.10.4705-4707.2003.
30. Chen JR, Lee SY, Yang BH, Lu JJ. Rapid identification and susceptibility testing using the VITEK 2 system using culture fluids from positive BacT/ALERT blood cultures. J Microbiol Immunol Infect 2008; 41:259-64; PMID:18629422.
31. Coyle MB, McGonagle LA, Plorde JJ, Clausen CR, Schoenknecht FD. Rapid antimicrobial susceptibility testing of isolates from blood cultures by direct inoculation and early reading of disk diffusion tests. J Clin Microbiol 1984; 20:473-7; PMID:6490830.
32. Edelmann A, Pietzcker T, Wellinghausen N. Comparison of direct disk diffusion and standard microtitre broth dilution susceptibility testing of blood culture isolates. J Med Microbiol 2007; 56:202-7; PMID:17244801; http://dx.doi.org/10.1099/jmm.0.46937-0.
33. Palka-Santini M, Pützfeld S, Cleven BE, Krönke M, Krut O. Rapid identification, virulence analysis and resistance profiling of Staphylococcus aureus by gene segment-based DNA microarrays: application to blood culture post-processing. J Microbiol Methods 2007; 68:468-77; PMID:17141897; http://dx.doi.org/10.1016/j.mimet.2006.10.004.
34. Fujita S, Yosizaki K, Ogushi T, Uechi K, Takemori Y, Senda Y. Rapid identification of gram-negative bacteria with and without CTX-M extended-spectrum β-lactamase from positive blood culture bottles by PCR followed by microchip gel electrophoresis. J Clin Microbiol 2011; 49:1483-8; PMID:21289149; http://dx.doi.org/10.1128/JCM.01976-10.
35. Cleven BE, Palka-Santini M, Gielen J, Meembor S, Krönke M, Krut O. Identification and characterization of bacterial pathogens causing bloodstream infections by DNA microarray. J Clin Microbiol 2006; 44:2389-97; PMID:16825354; http://dx.doi.org/10.1128/JCM.02291-05.
36. Naas T, Cuzon G, Truong H, Bernabeu S, Nordmann P. Evaluation of a DNA microarray, the check-points ESBL/KPC array, for rapid detection of TEM, SHV, and CTX-M extended-spectrum beta-lactamases and KPC carbapenemases. Antimicrob Agents Chemother 2010; 54:3086-92; PMID:20547813; http://dx.doi.org/10.1128/AAC.01298-09.
37. Naas T, Cuzon G, Bogaerts P, Glupczynski Y, Nordmann P. Evaluation of a DNA microarray (Check-MDR CT102) for rapid detection of TEM, SHV, and CTX-M extended-spectrum β-lactamases and of KPC, OXA-48, VIM, IMP, and NDM-1 carbapenemases. J Clin Microbiol 2011; 49:1608-13; PMID:21325547; http://dx.doi.org/10.1128/JCM.02607-10.
38. Stuart JC, Voets G, Scharringa J, Fluit AC, Leverstein-Van Hall MA. Detection of carbapenemase-producing Enterobacteriaceae with a commercial DNA microarray. J Med Microbiol 2012; 61:809-12; PMID:22383444; http://dx.doi.org/10.1099/jmm.0.041673-0.
39. Fishbain JT, Sinyavskiy O, Riederer K, Hujer AM, Bonomo RA. Detection of extended-spectrum β-lactamase and Klebsiella pneumoniae Carbapenemase genes directly from blood cultures by use of a nucleic acid microarray. J Clin Microbiol 2012; 50:2901-4; PMID:22718942; http://dx.doi.org/10.1128/JCM.01023-12.
40. Wintermans BB, Reuland EA, Wintermans RG, Bergmans AM, Kluytmans JA. The cost-effectiveness of ESBL detection: towards molecular detection methods? Clin Microbiol Infect 2012; In press; PMID:22971154; http://dx.doi.org/10.1111/j.1469-0691.2012.03998.x.
41. Spence RP, Wright V, Ala-Aldeen DA, Turner DP, Wooldridge KG, James R. Validation of virulence and epidemiology DNA microarray for identification and characterization of Staphylococcus aureus isolates. J Clin Microbiol 2008; 46:1620-7; PMID:18287310; http://dx.doi.org/10.1128/JCM.02453-07.
42. Pammi M, Flores A, Leeflang M, Versalovic J. Molecular assays in the diagnosis of neonatal sepsis: a systematic review and meta-analysis. Pediatrics 2011; 128:e973-85; PMID:21949139; http://dx.doi.org/10.1542/peds.2011-1208.
43. Waldeisen JR, Wang T, Mitra D, Lee LP. A realtime PCR antibiogram for drug-resistant sepsis. PLoS One 2011; 6:e28528; PMID:22164303; http://dx.doi.org/10.1371/journal.pone.0028528.
44. Ho YC, Chang SC, Lin SR, Wang WK. High levels of mecA DNA detected by a quantitative real-time PCR assay are associated with mortality in patients with methicillin-resistant Staphylococcus aureus bacteremia. J Clin Microbiol 2009; 47:1443-51; PMID:19279177; http://dx.doi.org/10.1128/JCM.01197-08.
45. Clinical trials: Establish Quantitative PCR to Measure Bacteria Load of the VRE Bacteremia. http://clinicaltrials.gov/ct2/show/NCT01265095 (last accessed on August 02, 2012).
46. Donskey CJ, Hoyen CK, Das SM, Helfand MS, Hecker MT. Recurrence of vancomycin-resistant Enterococcus stool colonization during antibiotic therapy. Infect Control Hosp Epidemiol 2002; 23:436-40; PMID:12186208; http://dx.doi.org/10.1086/502081.
47. Baden LR, Thiemke W, Skolnik A, Chambers R, Strymish J, Gold HS, et al. Prolonged colonization with vancomycin-resistant Enterococcus faecium in longterm care patients and the significance of "clearance". Clin Infect Dis 2001; 33:1654-60; PMID:11595985; http://dx.doi.org/10.1086/323762.
48. Ostrowsky BE, Venkataraman L, D'Agata EM, Gold HS, DeGirolami PC, Samore MH. Vancomycinresistant enterococci in intensive care units: high frequency of stool carriage during a non-outbreak period. Arch Intern Med 1999; 159:1467-72; PMID:10399898; http://dx.doi.org/10.1001/archinte.159.13.1467.
49. Planning commission further lowers poverty line to Rs. 28 per day. India Today. March 19, 2012. http://indiatoday.intoday.in/story/india-poverty-line-now-loweredto-rs-28-per-day/1/178483.html (last accessed on 03 August 2012).
50. World Bank. Data, India. http://data.worldbank.org/country/india (last accessed on 03 August 2012).
51. All India Institute of Medical Sciences. New Delhi, India. Revised rate of hospital charges. http://www.aiims.edu/aiims/hosp-serv/revised-rate-list.htm (last accessed on 03 August 2012).
52. Reddy P, Malczynski M, Obias A, Reiner S, Jin N, Huang J, et al. Screening for extended-spectrum betalactamase-producing Enterobacteriaceae among highrisk patients and rates of subsequent bacteremia. Clin Infect Dis 2007; 45:846-52; PMID:17806048; http://dx.doi.org/10.1086/521260.
53. Leonhardt KK, Yakusheva O, Phelan D, Reeths A, Hosterman T, Bonin D, et al. Clinical effectiveness and cost benefit of universal versus targeted methicillinresistant Staphylococcus aureus screening upon admission in hospitals. Infect Control Hosp Epidemiol 2011; 32:797-803; PMID:21768764; http://dx.doi.org/10.1086/660875.
54. Robotham JV, Graves N, Cookson BD, Barnett AG, Wilson JA, Edgeworth JD, et al. Screening, isolation, and decolonisation strategies in the control of meticillin resistant Staphylococcus aureus in intensive care units: cost effectiveness evaluation. BMJ 2011; 343:d5694; PMID:21980062; http://dx.doi.org/10.1136/bmj.d5694.
55. Brown J, Paladino JA. Impact of rapid methicillinresistant Staphylococcus aureus polymerase chain reaction testing on mortality and cost effectiveness in hospitalized patients with bacteraemia: a decision model. Pharmacoeconomics 2010; 28:567-75; PMID:20550222.
56. Hubben G, Bootsma M, Luteijn M, Glynn D, Bishai D, Bonten M, et al. Modelling the costs and effects of selective and universal hospital admission screening for methicillin-resistant Staphylococcus aureus. PLoS One 2011; 6:e14783; PMID:21483492; http://dx.doi.org/10.1371/journal.pone.0014783.
57. Shenoy ES, Walensky RP, Lee H, Orcutt B, Hooper DC. Resource burden associated with contact precautions for methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus: the patient access managers' perspective. Infect Control Hosp Epidemiol 2012; 33:849-52; PMID:22759555; http://dx.doi.org/10.1086/666629.
58. Kumar V, Sun P, Vamathevan J, Li Y, Ingraham K, Palmer L, et al. Comparative genomics of Klebsiella pneumoniae strains with different antibiotic resistance profiles. Antimicrob Agents Chemother 2011; 55:4267-76; PMID:21746949; http://dx.doi.org/10.1128/AAC.00052-11.
59. Sahl JW, Johnson JK, Harris AD, Phillippy AM, Hsiao WW, Thom KA, et al. Genomic comparison of multi-drug resistant invasive and colonizing Acinetobacter baumannii isolated from diverse human body sites reveals genomic plasticity. BMC Genomics 2011; 12:291; PMID:21639920; http://dx.doi.org/10.1186/1471-2164-12-291.
60. Totsika M, Beatson SA, Sarkar S, Phan MD, Petty NK, Bachmann N, et al. Insights into a multidrug resistant Escherichia coli pathogen of the globally disseminated ST131 lineage: genome analysis and virulence mechanisms. PLoS One 2011; 6:e26578; PMID:22053197; http://dx.doi.org/10.1371/journal.pone.0026578.
61. Fournier PE, Vallenet D, Barbe V, Audic S, Ogata H, Poirel L, et al. Comparative genomics of multidrug resistance in Acinetobacter baumannii. PLoS Genet 2006; 2:e7; PMID:16415984; http://dx.doi.org/10.1371/journal.pgen.0020007.
62. Tang BM, McLean AS, Dawes IW, Huang SJ, Lin RC. Gene-expression profiling of peripheral blood mononuclear cells in sepsis. Crit Care Med 2009; 37:882-8; PMID:19237892; http://dx.doi.org/10.1097/CCM.0b013e31819b52fd.
63. Laakso S, Kirveskari J, Tissari P, Mäki M. Evaluation of high-throughput PCR and microarray-based assay in conjunction with automated DNA extraction instruments for diagnosis of sepsis. PLoS One 2011; 6:e26655; PMID:22132076; http://dx.doi.org/10.1371/journal.pone.0026655.
64. Hoerr V, Zbytnuik L, Leger C, Tam PP, Kubes P, Vogel HJ. Gram-negative and Gram-Positive Bacterial Infections Give Rise to a Different Metabolic Response in a Mouse Model. J Proteome Res 2012; In press; PMID:22483232; http://dx.doi.org/10.1021/pr201274r.
65. Yu SL, Chen HW, Yang PC, Peck K, Tsai MH, Chen JJ, et al. Differential gene expression in gram-negative and gram-positive sepsis. Am J Respir Crit Care Med 2004; 169:1135-43; PMID:15001460; http://dx.doi.org/10.1164/rccm.200211-1278OC.
66. Tschudin-Sutter S, Frei R, Widmer AF. Equal efficacy of a generic piperacillin/tazobactam formulation: results of a local screening protocol. Diagn Microbiol Infect Dis 2011; 69:286-7; PMID:21353954; http://dx.doi.org/10.1016/j.diagmicrobio.2010.10.006.
67. Vesga O, Agudelo M, Salazar BE, Rodriguez CA, Zuluaga AF. Generic vancomycin products fail in vivo despite being pharmaceutical equivalents of the innovator. Antimicrob Agents Chemother 2010; 54:3271-9; PMID:20547818; http://dx.doi.org/10.1128/AAC.01044-09.
68. Zuluaga AF, Agudelo M, Cardeño JJ, Rodriguez CA, Vesga O. Determination of therapeutic equivalence of generic products of gentamicin in the neutropenic mouse thigh infection model. PLoS One 2010; 5:e10744; PMID:20505762; http://dx.doi.org/10.1371/journal.pone.0010744.
69. Moet GJ, Watters AA, Sader HS, Jones RN. Expanded studies of piperacillin/tazobactam formulations: variations among branded product lots and assessment of 46 generic lots. Diagn Microbiol Infect Dis 2009; 65:319-22; PMID:19822271; http://dx.doi.org/10.1016/j.diagmicrobio.2009.06.012.
70. Cuzon G, Naas T, Bogaerts P, Glupczynski Y, Nordmann P. Evaluation of a DNA microarray for the rapid detection of extended-spectrum β-lactamases (TEM, SHV and CTX-M), plasmid-mediated cephalosporinases (CMY-2-like, DHA, FOX, ACC-1, ACT/MIR and CMY-1-like/MOX) and carbapenemases (KPC, OXA-48, VIM, IMP and NDM). J Antimicrob Chemother 2012; 67:1865-9; PMID:22604450; http://dx.doi.org/10.1093/jac/dks156.
71. Diestra K, Juan C, Curiao T, Moyá B, Miró E, Oteo J, et al.; Red Española de Investigación en Patología Infecciosa (REIPI), Spain. Characterization of plasmids encoding blaESBL and surrounding genes in Spanish clinical isolates of Escherichia coli and Klebsiella pneumoniae. J Antimicrob Chemother 2009; 63:60-6; PMID:18988679; http://dx.doi.org/10.1093/jac/dkn453.
72. Khan AU, Nordmann P. Spread of carbapenemase NDM-1 producers: the situation in India and what may be proposed. Scand J Infect Dis 2012; 44:531-5; PMID:22497308; http://dx.doi.org/10.3109/00365548.2012.669046.
73. Isozumi R, Yoshimatsu K, Yamashiro T, Hasebe F, Nguyen BM, Ngo TC, et al. bla(NDM-1)-positive Klebsiella pneumoniae from environment, Vietnam. Emerg Infect Dis 2012; 18:1383-5; PMID:22840532.